The prognostic impact of treatment centralization in patients with testicular germ cell tumors: analysis of hospital-based cancer registry data in Japan
International Journal of Clinical Oncology · 2024
DOI: 10.1007/s10147-023-02457-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Clinical Oncology, 2024. Verfasst von Shuhei Suzuki und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan. Hauptthemen laut MEDLINE: Seminoma, Testicular Neoplasms, Neoplasms, Germ Cell and Embryonal. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: To identify the prognostic impact of treatment centralization in patients with testicular germ cell tumors (TGCT). METHODS: We used a hospital-based cancer registry data in Japan to extract seminoma and non-seminoma cases that were diagnosed in 2013, histologically confirmed, and received the first course of treatment. To compare the 5-years overall survival (OS) rates of patients stratified by institutional care volume, we performed a Cox proportional hazards regression analysis using inverse probability of treatment weighting (IPTW) method to adjust patient backgrounds. RESULTS: A total of 1767 TGCT patients were identified. The 5-years OS rates for stage II and III TGCT patients treated at low-volume institutions (< 7 cases) were significantly worse than high-volume institutions (≥ 7 cases) (91.2% vs. 83.4%, p = 0.012). Histological stratification revealed that 5-year OS rates for stage II and III seminoma patients in the low-volume group were significantly worse than the high-volume group (93.5% vs. 84.5%, p = 0.041). Multivariate OS analysis using an IPTW-matched cohort showed that institutional care volume was an independent prognostic factor (hazard ratio 2.13 [95% confidence interval: 1.23-3.71], p = 0.0072). CONCLUSION: Our results indicate that stage II and III TGCT patients experience lower survival rates at low-volume institutions and would benefit from treatment centralization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
- Department of Urology, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan. shuya79@md.tsukuba.ac.jp.
- International Medical Center, University of Tsukuba Affiliated Hospital, 2-1-1, Amakubo, Tsukuba, Ibaraki, 305-8576, Japan.
- Center for Cancer Registries, Institute for Cancer Control, National Cancer Center, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.
- Graduate School of Nursing, St Luke's International University, 10-1 Akashicho, Chuo-Ku, Tokyo, 104-0044, Japan.
Zitieren
APA
Suzuki, S., Nagumo, Y., Kandori, S., Kojo, K., Nitta, S., Chihara, I., Shiga, M., Ikeda, A., Kawahara, T., Hoshi, A., Negoro, H., Bryan, M. J., Okuyama, A., Higashi, T., & Nishiyama, H. (2024). The prognostic impact of treatment centralization in patients with testicular germ cell tumors: analysis of hospital-based cancer registry data in Japan. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-023-02457-0
Vancouver
Suzuki S, Nagumo Y, Kandori S, Kojo K, Nitta S, Chihara I, et al. The prognostic impact of treatment centralization in patients with testicular germ cell tumors: analysis of hospital-based cancer registry data in Japan. International Journal of Clinical Oncology. 2024. doi:10.1007/s10147-023-02457-0
BibTeX
@article{Suzuki2024,
author = {Suzuki, Shuhei and Nagumo, Yoshiyuki and Kandori, Shuya and Kojo, Kousuke and Nitta, Satoshi and Chihara, Ichiro and Shiga, Masanobu and Ikeda, Atsushi and Kawahara, Takashi and Hoshi, Akio and Negoro, Hiromitsu and Bryan, Mathis J and Okuyama, Ayako and Higashi, Takahiro and Nishiyama, Hiroyuki},
title = {The prognostic impact of treatment centralization in patients with testicular germ cell tumors: analysis of hospital-based cancer registry data in Japan},
journal = {International Journal of Clinical Oncology},
year = {2024},
doi = {10.1007/s10147-023-02457-0}
}
EUVIMED